Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of CDC-9 Inactivated Rotavirus Vaccine Microneedle Patch in Healthy Adults
NCT06962904Phase 1Active, not recruiting
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jul 2025
- Primary completion
- Oct 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CDC-9 Inactivated Rotavirus Vaccine in rotavirus infection (3 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoints: Any unsolicited adverse events, Any serious adverse events and 4 more. Started Jul 2025; status: active, not recruiting.
02
Drugs
CDC-9 Inactivated Rotavirus Vaccine
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT06962904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06962904.